Table 3.

Adverse events.

	TXA (n=4,423)	No TXA (n=18,998)	Unadjusted Odds Ratio (95% CI)	p-value	Adjusted Odds Ratio (95% CI)	p-value
DVT at 30 days	11 (0.2)	47 (0.2)	0.87 (0.43–1.76)	0.70	0.92 (0.45–1.88)	0.82
PE at 30 days	39 (0.9)	119 (0.6)	1.37 (0.92–2.04)	0.12	1.20 (0.80–1.79)	0.39
MI at 30 days	8 (0.2)	50 (0.3)	0.70 (0.32–1.53)	0.37	0.78 (0.34–1.77)	0.55
Stroke at 30 days	5 (0.1)	17 (0.1)	1.12 (0.40–3.16)	0.82	1.17 (0.41–3.37)	0.77
Readmission 30 days	246 (5.6)	1,384 (7.3)	0.94 (0.80–1.10)	0.44	1.02 (0.86–1.20)	0.83
Readmission 90 days	327 (7.4)	1,748 (9.2)	0.95 (0.82–1.09)	0.44	1.03 (0.89–1.20)	0.68

Abbreviations: TXA, tranexamic acid; CI, confidence interval; DVT, deep vein thrombosis; PE, pulmonary embolus; MI, myocardial infarction. There were no statistically significant values.